BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25812467)

  • 21. Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
    Bień K; Sokołowska J; Bąska P; Nowak Z; Stankiewicz W; Krzyzowska M
    Mediators Inflamm; 2015; 2015():281613. PubMed ID: 25873756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.
    Golan-Gerstl R; Wallach-Dayan SB; Zisman P; Cardoso WV; Goldstein RH; Breuer R
    Am J Respir Cell Mol Biol; 2012 Sep; 47(3):271-9. PubMed ID: 22582174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of soluble Fas Ligand in germ cell apoptosis in testis of rats undergoing autoimmune orchitis.
    Jacobo PV; Fass M; Pérez CV; Jarazo-Dietrich S; Lustig L; Theas MS
    Cytokine; 2012 Nov; 60(2):385-92. PubMed ID: 22892327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice.
    Aoshiba K; Yasui S; Tamaoki J; Nagai A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):695-700. PubMed ID: 10934108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
    Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
    J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J; Xu G
    Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT1 Deficiency, Specifically in Fibroblasts, Decreases Apoptosis Resistance and Is Associated with Resolution of Lung-Fibrosis.
    Bulvik R; Breuer R; Dvir-Ginzberg M; Reich E; Berkman N; Wallach-Dayan SB
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleomycin-Treated Chimeric Thy1-Deficient Mice with Thy1-Deficient Myofibroblasts and Thy-Positive Lymphocytes Resolve Inflammation without Affecting the Fibrotic Response.
    Cohen PY; Breuer R; Zisman P; Wallach-Dayan SB
    Mediators Inflamm; 2015; 2015():942179. PubMed ID: 26300593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis.
    Wynes MW; Edelman BL; Kostyk AG; Edwards MG; Coldren C; Groshong SD; Cosgrove GP; Redente EF; Bamberg A; Brown KK; Reisdorph N; Keith RC; Frankel SK; Riches DW
    J Immunol; 2011 Jul; 187(1):527-37. PubMed ID: 21632719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
    Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
    Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
    Oyaizu N; Kayagaki N; Yagita H; Pahwa S; Ikawa Y
    Biochem Biophys Res Commun; 1997 Sep; 238(2):670-5. PubMed ID: 9299572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
    Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
    Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.